Stockscreener 앱 받기
10.08
2.54%
0.25
전일 마감가:
$9.83
열려 있는:
$9.665
하루 거래량:
1.68M
Relative Volume:
0.35
시가총액:
$2.40B
수익:
$510.17M
순이익/손실:
$146.93M
주가수익비율:
16.83
EPS:
0.599
순현금흐름:
$27.51M
1주 성능:
+9.68%
1개월 성능:
-36.24%
6개월 성능:
-31.61%
1년 성능:
-48.01%
1일 변동 폭
$9.60
$10.15
1주일 범위
$9.09
$10.15
52주 변동 폭
$7.2101
$25.67
Adma Biologics Inc Stock (ADMA) Company Profile
명칭
Adma Biologics Inc
전화
(201) 478-5552
주소
C/O ADMA BIOLOGICS, INC., RAMSEY
Compare ADMA vs VRTX, REGN, ARGX, ALNY, ONC
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ADMA
Adma Biologics Inc
|
10.08 | 2.34B | 510.17M | 146.93M | 27.51M | 0.599 |
VRTX
Vertex Pharmaceuticals Inc
|
442.22 | 112.92B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
765.67 | 81.99B | 14.34B | 4.50B | 3.77B | 41.56 |
ARGX
Argen X Se Adr
|
796.04 | 48.82B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
324.45 | 43.66B | 3.71B | 313.75M | 465.38M | 2.2571 |
ONC
Beone Medicines Ltd Adr
|
316.52 | 34.65B | 5.36B | 287.73M | 924.18M | 2.5229 |
Adma Biologics Inc Stock (ADMA) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-03-26 | 다운그레이드 | Cantor Fitzgerald | Overweight → Neutral |
| 2023-07-19 | 재개 | Raymond James | Strong Buy |
| 2022-10-13 | 개시 | Mizuho | Buy |
| 2021-11-11 | 업그레이드 | Raymond James | Outperform → Strong Buy |
| 2021-11-09 | 개시 | Cantor Fitzgerald | Overweight |
| 2019-06-04 | 개시 | Jefferies | Buy |
| 2019-04-15 | 재확인 | H.C. Wainwright | Buy |
| 2019-02-07 | 재개 | H.C. Wainwright | Buy |
| 2017-12-11 | 재확인 | Maxim Group | Buy |
| 2017-11-14 | 업그레이드 | Raymond James | Mkt Perform → Outperform |
| 2017-01-23 | 업그레이드 | Maxim Group | Hold → Buy |
| 2016-08-01 | 다운그레이드 | Maxim Group | Buy → Hold |
| 2016-07-25 | 재확인 | Maxim Group | Buy |
| 2015-05-13 | 재확인 | Maxim Group | Buy |
| 2014-12-08 | 개시 | Oppenheimer | Outperform |
| 2014-12-01 | 재확인 | Maxim Group | Buy |
모두보기
Adma Biologics Inc 주식(ADMA)의 최신 뉴스
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ADMA Biologics, Inc.ADMA - PR Newswire
ADMA Fraud Notice: ADMA Biologics Investors are Notified the Company is being Investigated for Securities Fraud after 29% Stock Drop — BFA Law - Business Wire
Advantage Alpha Capital Partners LP's ADMA Biologics Inc(ADMA) Holding History - GuruFocus
Bragar Eagel & Squire, P.C. Urges ADMA Biologics, Inc. - GlobeNewswire
Bragar Eagel & Squire, P.C. Urges ADMA Biologics, Inc. (NASDAQ:ADMA) Investors to Contact the Firm Regarding Ongoing Investigation - GlobeNewswire Inc.
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against ADMA Biologics, Inc. (ADMA) And Encourages Shareholders to Reach Out - ACCESS Newswire
ADMA Technical Analysis & Stock Price Forecast - Intellectia AI
Lowey Dannenberg, P.C. is Investigating ADMA Biologics (NASDAQ: ADMA) for Potential Violations of the Federal Securities Laws and Encourages Investors with more than $50,000 in Losses to Contact the Firm - The Globe and Mail
ADMA Investor Announcement: ADMA Biologics Investigated - GlobeNewswire
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against ADMA Biologics, Inc. (ADMA) and Encourages Shareholders to Learn More About the Investigation - ACCESS Newswire
ADMA Biologics Under Investigation for Securities Violations - Intellectia AI
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ADMA ... - Bluefield Daily Telegraph
ADMA Biologics: The Short Report Is The Noise, Not The Signal (NASDAQ:ADMA) - Seeking Alpha
Aberdeen Group Reduces ADMA Biologics Stake - National Today
ADMA Biologics gains after refuting short seller claims - MSN
ADMA Biologics Inc $ADMA Stock Holdings Lessened by Aberdeen Group plc - MarketBeat
ADMA INVESTOR ALERT: Kirby McInerney LLP Investigates Potential Claims Involving ADMA Biologics, Inc. - ACCESS Newswire
ADMA stock downgraded by Cantor as ‘channel stuffing’ claims shake investor confidence - MSN
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against ADMA Biologics, Inc. (ADMA) and Encourages Investors to Learn More About the Investigation - ACCESS Newswire
ADMA Biologics, Inc. (ADMA) Crashes 16% Amid Scrutiny Over - GlobeNewswire
Shareholder News: ADMA Biologics (NASDAQ:ADMA) Drops 29% - GlobeNewswire
Allspring Global Investments Holdings LLC Decreases Stock Position in ADMA Biologics Inc $ADMA - MarketBeat
ADMA Biologics slams short seller claims, highlights strong demand - MSN
ADMA Biologics extends selloff as Cantor downgrades after short report - MSN
ADMA Biologics, Inc. (ADMA) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
2026-04-05 | ADMA Biologics, Inc. (ADMA) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation | NDAQ:ADMA | Press Release - Stockhouse
ADMA SEC FilingsAdma Biologics 10-K, 10-Q, 8-K Forms - Stock Titan
ADMA PE Ratio & Valuation, Is ADMA Overvalued - intellectia.ai
US High Growth Tech Stocks To Watch For Potential Expansion - Sahm
Stock Drop Alert: ADMA Biologics ($ADMA) Stock Plummets 29% after Channel Stuffing Claims DisclosedInvestors Notified of Securities Fraud Investigation - ACCESS Newswire
Bronstein, Gewirtz & Grossman, LLC Is Investigating ADMA Biologics, Inc. (ADMA) And Encourages Investors to Connect - ACCESS Newswire
ADMA Biologics Under Investigation for Securities Fraud Allegations - Intellectia AI
ADMA (ADMA) COO reports 20,362-share RSU tax withholding, holds 446,238 shares - Stock Titan
2026-04-03 | Bronstein, Gewirtz & Grossman, LLC Is Investigating ADMA Biologics, Inc. (ADMA) And Encourages Investors to Connect | NDAQ:ADMA | Press Release - Stockhouse
ADMA Biologics Investigated for Securities Fraud After Plunge - National Today
Bronstein, Gewirtz & Grossman, LLC Encourages ADMA Biologics, Inc. (ADMA) Stockholders to Inquire about Securities Investigation - ACCESS Newswire
Short seller report alleges ADMA Biologics financial misrepresentation - MSN
Trading the Move, Not the Narrative: (ADMA) Edition - Stock Traders Daily
ADMA Investor Alert: ADMA Biologics Securities Fraud LawsuitInvestors With Losses May Seek to Lead the Class Action After Company Allegedly Concealed Revenue Headwinds: Levi & Korsinsky - Sahm
Rosen Law Firm Encourages ADMA Biologics, Inc. Investors to Inqui - The National Law Review
Rosen Law Firm Encourages ADMA Biologics, Inc. Investors to Inquire About Securities Class Action Investigation – ADMA - eagletribune.com
ADMA Biologics Inc (ADMA) Stock Forecasts - Yahoo Finance
Will Lead Drug Asceniv Fuel ADMA's Top-Line Growth in 2026? - Zacks Investment Research
ADMA Biologics Under Investigation for Securities Fraud - Intellectia AI
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against ADMA Biologics, Inc. (ADMA) And Encourages Investors to Reach Out - ACCESS Newswire
Investor Notice: ADMA Biologics ($ADMA) Stock Dropped 29% After Culper Research Report AnnouncementInvestigation Pending - ACCESS Newswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of ADMA ... - Bluefield Daily Telegraph
ADMA SHAREHOLDER ALERT: Investors Encouraged to Contact Kirby McInerney LLP About Potential ... - Bluefield Daily Telegraph
Adma Biologics (ADMA) Stock Declines While Market Improves: Some Information for Investors - Yahoo Finance
ADMA Biologics Investigated for Securities Fraud After Stock Drop - National Today
ADMA Biologics Investigated for Securities Fraud After Plummeting Stock - National Today
Adma Biologics Inc (ADMA) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.00%
1.95%
자본화:
|
볼륨(24시간):